AAAAAA

   
Results: 1-21 |
Results: 21
HIGH-DOSE CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER
Authors: PRICE LA
Citation: La. Price, HIGH-DOSE CHEMOTHERAPY IN HIGH-RISK BREAST-CANCER, Lancet, 352(9139), 1998, pp. 1551-1552
A LINEAR HEXAPEPTIDE SOMATOSTATIN ANTAGONIST BLOCKS SOMATOSTATIN ACTIVITY IN-VITRO AND INFLUENCES GROWTH-HORMONE RELEASE IN RATS
Authors: BAUMBACH WR CARRICK TA PAUSCH MH BINGHAM B CARMIGNAC D ROBINSON ICAF HOUGHTEN R EPPLER CM PRICE LA ZYSK JR
Citation: Wr. Baumbach et al., A LINEAR HEXAPEPTIDE SOMATOSTATIN ANTAGONIST BLOCKS SOMATOSTATIN ACTIVITY IN-VITRO AND INFLUENCES GROWTH-HORMONE RELEASE IN RATS, Molecular pharmacology, 54(5), 1998, pp. 864-873
INVESTIGATION OF GROWTH-HORMONE RELEASING HORMONE-RECEPTOR STRUCTURE AND ACTIVITY USING YEAST EXPRESSION TECHNOLOGIES
Authors: KAJKOWSKI EM PRICE LA PAUSCH MH YOUNG KH OZENBERGER BA
Citation: Em. Kajkowski et al., INVESTIGATION OF GROWTH-HORMONE RELEASING HORMONE-RECEPTOR STRUCTURE AND ACTIVITY USING YEAST EXPRESSION TECHNOLOGIES, Journal of receptor and signal transduction research, 17(1-3), 1997, pp. 293-303
MAMMALIAN 2P POTASSIUM CHANNELS EXPRESSED IN SACCHAROMYCES-CEREVISIAEAND XENOPUS-LAEVIS CELLS
Authors: PRICE LA HELLINGS SE HAYASHI J PAUSCH MH
Citation: La. Price et al., MAMMALIAN 2P POTASSIUM CHANNELS EXPRESSED IN SACCHAROMYCES-CEREVISIAEAND XENOPUS-LAEVIS CELLS, The FASEB journal, 11(9), 1997, pp. 655-655
CHOLECYSTOKININ RECEPTORS FUNCTIONALLY COUPLED TO THE SACCHAROMYCES-CEREVISIAE MATING SIGNAL-TRANSDUCTION PATHWAY
Authors: PAUSCH MH PRICE LA DUNLOP J HADCOCK JR
Citation: Mh. Pausch et al., CHOLECYSTOKININ RECEPTORS FUNCTIONALLY COUPLED TO THE SACCHAROMYCES-CEREVISIAE MATING SIGNAL-TRANSDUCTION PATHWAY, The FASEB journal, 11(9), 1997, pp. 1117-1117
IDENTIFICATION AND CHARACTERIZATION OF NOVEL SOMATOSTATIN ANTAGONISTS(VOL 50, PG 709, 1996)
Authors: BASS RT BUCKWALTER BL PATEL BP PAUSCH MH PRICE LA STRNAD J HADCOCK JR
Citation: Rt. Bass et al., IDENTIFICATION AND CHARACTERIZATION OF NOVEL SOMATOSTATIN ANTAGONISTS(VOL 50, PG 709, 1996), Molecular pharmacology, 51(1), 1997, pp. 170-170
ORK1, A K-SELECTIVE LEAK CHANNEL CLONED FROM DROSOPHILA-MELANOGASTER BY EXPRESSION IN SACCHAROMYCES-CEREVISIAE, A MEMBER OF A NEW 2-P DOMAIN K+ CHANNEL FAMILY()
Authors: GOLDSTEIN DAN PRICE LA ROSENTHAL DN PAUSCH MH
Citation: Dan. Goldstein et al., ORK1, A K-SELECTIVE LEAK CHANNEL CLONED FROM DROSOPHILA-MELANOGASTER BY EXPRESSION IN SACCHAROMYCES-CEREVISIAE, A MEMBER OF A NEW 2-P DOMAIN K+ CHANNEL FAMILY(), Biophysical journal, 72(2), 1997, p.
ADJUSTED-DOSE WARFARIN VERSUS LOW-INTENSITY, FIXED-DOSE WARFARIN PLUSASPIRIN FOR HIGH-RISK PATIENTS WITH ATRIAL-FIBRILLATION - STROKE PREVENTION IN ATRIAL-FIBRILLATION-III RANDOMIZED CLINICAL-TRIAL
Authors: BLACKSHEAR JL BAKER VS RUBINO F SAFFORD R LANE G FLIPSE T MALOUF J THOMPSON R WEBEL R FLAKER GC YOUNG L HESS D FRIEDMAN G BURGER R MCANULTY JH COULL BM MARCHANT C TIMBERG J JANZIK C GIRAUD G HALPERIN B KRON J WYNN M RAITT M ANDERSON DC ASINGER RW NEWBURG SM FIFIELD J BUNDLIE SR KOLLER RL TARREL RD DICK C HAUGLAND JM JORGENSEN CR LEONARD AD KANTER MC SOLOMON DH ZABALGOITIA M MEGO D CARTER JE BOYD SY BOOP BS LALONDE D MODLIN R LOGAN WR GREEN BJ HAMILTON WP MEZEI L RIGGIO S FELDMAN G HAYWARD A STRAUSS R ANDERSON W GROVER J MCKENZIE M HARTMCARTHUR P GRAMBERG M HOUSTON H HALPERIN JL ROTHAUF EB WEINBERGER JM GOLDMAN ME LAUPACIS A CHAN KL BOURQUE P BIGGS J IVES A FEINBERG WM KERN KB PENNOCK GD FENSTER PE HUERTA BJ OHM J DITTRICH HC KERRIDGE C KEEN W SWENSON M KOPECKY SL LITIN SC WIEBERS DO HOLLAND AE BROWN RD KHANDHERIA BK MEISSNER I TUCKER KR ROTHBART R TORELLI J SCHMIDT J MURRAY D RUZICH RS LOUTFI H APPLETON C INGALL T CARLSON L WILSON D DUNN M NOLTE B EDWARDS C DICK A PRICE LA JANOSIK DL BJERREGAARD P QUATTROMANI A SCHILLER L LABOVITZ A BURCH C PARKS BJ THOMPSON D BERARDUCCI L CAREY S VIGIL A FALK R BATTINELLI N MCNEIL M DAVIDOFF R BERNARD S BERGETHON P FIORI L ALBERS G ATWOOD E CLARK J TONG D YENARI M FROELICKER V LUTSEP H HOCK NH QUAGLIETTI S KEMP S ALPERT MA ROTHROCK JF HUPP CH MASSEY CV HAMILTON WJ MILLER VT FOX J
Citation: Jl. Blackshear et al., ADJUSTED-DOSE WARFARIN VERSUS LOW-INTENSITY, FIXED-DOSE WARFARIN PLUSASPIRIN FOR HIGH-RISK PATIENTS WITH ATRIAL-FIBRILLATION - STROKE PREVENTION IN ATRIAL-FIBRILLATION-III RANDOMIZED CLINICAL-TRIAL, Lancet, 348(9028), 1996, pp. 633-638
CHRONIC COPPER TOXICOSIS PRESENTING AS LIVER-FAILURE IN AN AUSTRALIANCHILD
Authors: PRICE LA WALKER NI CLAGUE AE PULLEN ID SMITS JS ONG TH PATRICK M
Citation: La. Price et al., CHRONIC COPPER TOXICOSIS PRESENTING AS LIVER-FAILURE IN AN AUSTRALIANCHILD, Pathology, 28(4), 1996, pp. 316-320
ORK1, A POTASSIUM-SELECTIVE LEAK CHANNEL WITH 2 PORE DOMAINS CLONED FROM DROSOPHILA-MELANOGASTER BY EXPRESSION IN SACCHAROMYCES-CEREVISIAE
Authors: GOLDSTEIN SAN PRICE LA ROSENTHAL DN PAUSCH MH
Citation: San. Goldstein et al., ORK1, A POTASSIUM-SELECTIVE LEAK CHANNEL WITH 2 PORE DOMAINS CLONED FROM DROSOPHILA-MELANOGASTER BY EXPRESSION IN SACCHAROMYCES-CEREVISIAE, Proceedings of the National Academy of Sciences of the United Statesof America, 93(23), 1996, pp. 13256-13261
IDENTIFICATION AND CHARACTERIZATION OF NOVEL SOMATOSTATIN ANTAGONISTS
Authors: BASS RT BUCKWALTER BL PATEL BP PAUSCH MH PRICE LA STRNAD J HADCOCK JR
Citation: Rt. Bass et al., IDENTIFICATION AND CHARACTERIZATION OF NOVEL SOMATOSTATIN ANTAGONISTS, Molecular pharmacology, 50(4), 1996, pp. 709-715
PHARMACOLOGICAL CHARACTERIZATION OF THE RAT A(2A) ADENOSINE RECEPTOR FUNCTIONALLY COUPLED TO THE YEAST PHEROMONE RESPONSE PATHWAY
Authors: PRICE LA STRNAD J PAUSCH MH HADCOCK JR
Citation: La. Price et al., PHARMACOLOGICAL CHARACTERIZATION OF THE RAT A(2A) ADENOSINE RECEPTOR FUNCTIONALLY COUPLED TO THE YEAST PHEROMONE RESPONSE PATHWAY, Molecular pharmacology, 50(4), 1996, pp. 829-837
CREATING SUPPORTIVE COMMUNITIES FOR ADOLESCENT DEVELOPMENT - CHALLENGES TO SCHOLARS - AN INTRODUCTION
Authors: ZELDIN S PRICE LA
Citation: S. Zeldin et La. Price, CREATING SUPPORTIVE COMMUNITIES FOR ADOLESCENT DEVELOPMENT - CHALLENGES TO SCHOLARS - AN INTRODUCTION, Journal of adolescent research, 10(1), 1995, pp. 6-14
FUNCTIONAL COUPLING OF A MAMMALIAN SOMATOSTATIN RECEPTOR TO THE YEASTPHEROMONE RESPONSE PATHWAY
Authors: PRICE LA KAJKOWSKI EM HADCOCK JR OZENBERGER BA PAUSCH MH
Citation: La. Price et al., FUNCTIONAL COUPLING OF A MAMMALIAN SOMATOSTATIN RECEPTOR TO THE YEASTPHEROMONE RESPONSE PATHWAY, Molecular and cellular biology, 15(11), 1995, pp. 6188-6195
PARAQUAT AND DIQUAT INTERFERENCE IN THE ANALYSIS OF CREATININE BY THEJAFFE REACTION
Authors: PRICE LA NEWMAN KJ CLAGUE AE WILSON PR WENCK DJ
Citation: La. Price et al., PARAQUAT AND DIQUAT INTERFERENCE IN THE ANALYSIS OF CREATININE BY THEJAFFE REACTION, Pathology, 27(2), 1995, pp. 154-156
HIERARCHICAL ENCODING OF TEXT - TECHNICAL PROBLEMS AND SGML SOLUTIONS
Authors: BARNARD DT BURNARD L GASPART JP PRICE LA SPERBERGMCQUEEN CM VARILE GB
Citation: Dt. Barnard et al., HIERARCHICAL ENCODING OF TEXT - TECHNICAL PROBLEMS AND SGML SOLUTIONS, Computers and the humanities, 29(3), 1995, pp. 211-231
SURVIVAL IN ADVANCED BREAST-CANCER - COMBINATION CHEMOTHERAPY IMPROVES OUTLOOK
Authors: PRICE LA
Citation: La. Price, SURVIVAL IN ADVANCED BREAST-CANCER - COMBINATION CHEMOTHERAPY IMPROVES OUTLOOK, BMJ. British medical journal, 308(6936), 1994, pp. 1103-1103
LACK OF SURVIVAL ADVANTAGE IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMAS OF THE ORAL CAVITY RECEIVING NEOADJUVANT CHEMOTHERAPY PRIOR TO LOCAL THERAPY, DESPITE ACHIEVING AN INITIAL HIGH CLINICAL COMPLETE REMISSION RATE
Authors: HILL BT PRICE LA
Citation: Bt. Hill et La. Price, LACK OF SURVIVAL ADVANTAGE IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMAS OF THE ORAL CAVITY RECEIVING NEOADJUVANT CHEMOTHERAPY PRIOR TO LOCAL THERAPY, DESPITE ACHIEVING AN INITIAL HIGH CLINICAL COMPLETE REMISSION RATE, American journal of clinical oncology, 17(1), 1994, pp. 1-5
WHEN ACADEMIC ASSISTANCE IS NOT ENOUGH - ADDRESSING THE MENTAL-HEALTHISSUES OF ADOLESCENTS AND ADULTS WITH LEARNING-DISABILITIES
Authors: PRICE LA JOHNSON JM EVELO S
Citation: La. Price et al., WHEN ACADEMIC ASSISTANCE IS NOT ENOUGH - ADDRESSING THE MENTAL-HEALTHISSUES OF ADOLESCENTS AND ADULTS WITH LEARNING-DISABILITIES, Journal of learning disabilities, 27(2), 1994, pp. 82-90
CAUSES OF HIGHER IN-HOSPITAL MORTALITY IN WOMEN THAN IN MEN AFTER ACUTE MYOCARDIAL-INFARCTION
Authors: JENKINS JS FLAKER GC NOLTE B PRICE LA MORRIS D KURZ J PETROSKI GF
Citation: Js. Jenkins et al., CAUSES OF HIGHER IN-HOSPITAL MORTALITY IN WOMEN THAN IN MEN AFTER ACUTE MYOCARDIAL-INFARCTION, The American journal of cardiology, 73(5), 1994, pp. 319-322
LARYNX PRESERVATION AFTER INITIAL NON-CISPLATIN CONTAINING COMBINATION CHEMOTHERAPY PLUS RADIOTHERAPY, AS OPPOSED TO SURGICAL INTERVENTION WITH OR WITHOUT RADIOTHERAPY IN PREVIOUSLY UNTREATED ADVANCED HEAD ANDNECK-CANCER - FINAL ANALYSIS AFTER 12 YEARS FOLLOW-UP
Authors: PRICE LA SHAW HJ HILL BT
Citation: La. Price et al., LARYNX PRESERVATION AFTER INITIAL NON-CISPLATIN CONTAINING COMBINATION CHEMOTHERAPY PLUS RADIOTHERAPY, AS OPPOSED TO SURGICAL INTERVENTION WITH OR WITHOUT RADIOTHERAPY IN PREVIOUSLY UNTREATED ADVANCED HEAD ANDNECK-CANCER - FINAL ANALYSIS AFTER 12 YEARS FOLLOW-UP, Journal of Laryngology and Otology, 107(3), 1993, pp. 211-216
Risultati: 1-21 |